Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Phase II/III Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS

NCT06126315 is registered in ClinicalTrials.gov with Mario Negri Institute for Pharmacological Research as lead sponsor.

NCT NCT06126315
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06126315 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Phase II/III Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS
Lead sponsor
Mario Negri Institute for Pharmacological Research
Phase
Phase 2/3
Overall status
Recruiting
Start date
March 26, 2025
Completion date
September 30, 2027
Enrollment
246 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

amyotrophic lateral sclerosis